Liver Cirrhosis Diagnostic Tests: Introduction

  • Liver cirrhosis, also called hepatic cirrhosis, is a progressive chronic medical condition characterized by the development of scar tissues in replacement with healthy liver tissues
  • In liver cirrhosis, healthy liver tissues are destroyed and replaced by scar tissue, and the condition starts blocking of blood flow through the liver
  • Liver cirrhosis is primarily caused by underlying liver diseases such as hepatitis, fatty liver disease, toxic metals, and excessive alcoholism
  • Symptoms of liver cirrhosis do not appear in the primary stages of the disease; however, the normal functioning of the liver is affected as the disease progresses, leading to the exhibition of symptoms. The common symptoms of liver cirrhosis include loss of appetite, weight loss, visibility of blood capillaries on the skin and upper abdomen, pain in the abdomen, and nausea.
  • Diagnosis of liver disease is carried out by various tests, which includes blood tests, imaging tests, biopsy tests, and endoscopy tests

 Request Brochure for Report -

Liver Cirrhosis Diagnostic Tests Market: Key Drivers

  • High prevalence and rise in incidence of liver disorders such as hepatitis, fatty liver disease, and excessive alcoholism across the globe are key factors driving the liver cirrhosis diagnostic tests market
  • For instance, around 2 billion people across the globe are estimated to have either had or currently living with some form of hepatitis viral infection. According to World Health Organization, in 2016 around 399,000 people died worldwide due to hepatitis C, liver cirrhosis, and hepatocellular carcinoma.
  • Technological advancements in diagnostic tools, such biopsy tests, imaging tests, and endoscopic tests and a rise in the demand for liver cirrhosis tests are estimated to contribute to propel the market during the forecast period
  • High cost of imaging tests and lack of skilled professionals in low and middle income countries are likely to restrain the market during the forecast period

 Request for Analysis of COVID19 Impact on Liver Cirrhosis Diagnostic Tests Market –

Increase in demand for minimally invasive surgeries

Minimally invasive surgery is a relatively new method of surgery. Minimally invasive surgery does not need a large of a dose of pain relievers because the incision during surgery is much smaller. The procedure involves minimizing surgical incisions to reduce trauma to the body. This type of surgery is usually performed using thin-needles and an endoscope to visually guide the surgery. The change was initiated with the advent of the laparoscopic surgery, and because of the rapid acceptance and success of operations, such as laparoscopic cholecystectomy. Moreover, a revolution has taken place in general surgery over the last two decades. Surgeons have rapidly adopted minimally invasive surgical (MIS) techniques for a wide range of applications such as cholecystectomy, appendectomy, gastric bypass, ventral hernia repair, colectomy, prostatectomy, tubal ligation, hysterectomy, and myomectomy.

 Pre book Market Report -

Liver Biopsy Tests Segment to be Highly Attractive

  • In terms of tests, the global market can be segmented into blood tests, biopsy tests, and imaging tests. The liver biopsy tests segment is projected to dominate the global market during the forecast period.
  • Liver biopsy tests involve extraction of a tissue sample from the liver for clinical examination. The liver biopsy procedure is usually performed by fine needle aspiration using endoscopic ultrasound for the detailed examination liver.
  • The biopsy test is considered as the gold standard as this technique helps detect a wide range of liver diseases without the need for repeated samplings. Moreover, easy sampling and diagnosis owing to technological advancements have led to the wide acceptance of this test among end-users     

 Ask for Discount :

Key Players Operating in Global Liver Cirrhosis Diagnostics Tests Market

  • The global liver cirrhosis diagnostics tests market is fragmented, with a large number of global players holding a majority share. Prominent players operating in the global liver cirrhosis diagnostic tests market include:
    • Laboratory Corporation of America Holdings
    • Hologic Inc.
    • Olympus Corporation
    • Stryker Corporation
    • BioPredictive
    • Koninklijke Philips N.V.
    • Canon Medical Systems Corporation
    • Argon Medical Devices, Inc.

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.


Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453